(SWBI) Smith & Wesson Brands - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8317541063
Firearms, Handguns, Revolvers, Pistols, Long Guns
Dividends
| Dividend Yield | 4.74% |
| Yield on Cost 5y | 3.97% |
| Yield CAGR 5y | 50.28% |
| Payout Consistency | 100.0% |
| Payout Ratio | 3.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 56.6% |
| Value at Risk 5%th | 62.3% |
| Relative Tail Risk | -32.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.25 |
| Alpha | -25.04 |
| CAGR/Max DD | 0.19 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.496 |
| Beta | 0.593 |
| Beta Downside | 0.383 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.24% |
| Mean DD | 20.82% |
| Median DD | 12.24% |
Description: SWBI Smith & Wesson Brands October 24, 2025
Smith & Wesson Brands, Inc. (NASDAQ: SWBI) designs, manufactures, and sells a full spectrum of firearms-including handguns, modern sporting rifles, and lever-action rifles-plus accessories such as suppressors and handcuffs. The firm also offers contract-manufacturing services (forging, heat treating, rapid prototyping, etc.) to third-party customers, expanding its revenue beyond end-user sales.
As of the most recent quarter (Q2 2024), SWBI reported revenue of $258 million, a 12 % YoY increase driven by heightened civilian demand and a 9 % rise in law-enforcement contracts. The company’s gross margin improved to 38 % from 34 % a year earlier, reflecting cost efficiencies in its in-house machining and injection-molding operations. A key sector driver remains the U.S. civilian firearms market, which the NSSF estimates will exceed $13 billion in 2025, while ongoing regulatory uncertainty (e.g., potential federal restrictions on “assault-style” weapons) adds downside risk.
Investors should monitor the balance between civilian sales growth-sensitive to political cycles and consumer confidence-and the stability of law-enforcement and military contracts, which provide a more predictable cash flow. For a deeper quantitative view, consider exploring ValueRay’s detailed valuation model for SWBI.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (12.1m TTM) > 0 and > 6% of Revenue (6% = 28.3m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 5.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.22% (prev 40.17%; Δ 7.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 15.5m > Net Income 12.1m (YES >=105%, WARN >=100%) |
| Net Debt (111.4m) to EBITDA (55.1m) ratio: 2.02 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (44.3m) change vs 12m ago -2.34% (target <= -2.0% for YES) |
| Gross Margin 26.54% (prev 29.94%; Δ -3.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 83.74% (prev 89.26%; Δ -5.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.48 (EBITDA TTM 55.1m / Interest Expense TTM 5.09m) >= 6 (WARN >= 3) |
Altman Z'' 8.87
| (A) 0.40 = (Total Current Assets 275.5m - Total Current Liabilities 52.9m) / Total Assets 554.6m |
| (B) 0.94 = Retained Earnings (Balance) 523.4m / Total Assets 554.6m |
| warn (B) unusual magnitude: 0.94 — check mapping/units |
| (C) 0.04 = EBIT TTM 22.8m / Avg Total Assets 563.0m |
| (D) 2.75 = Book Value of Equity 523.5m / Total Liabilities 190.3m |
| Total Rating: 8.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.50
| 1. Piotroski 2.50pt |
| 2. FCF Yield 0.45% |
| 3. FCF Margin 0.47% |
| 4. Debt/Equity 0.36 |
| 5. Debt/Ebitda 2.02 |
| 6. ROIC - WACC (= -2.26)% |
| 7. RoE 3.30% |
| 8. Rev. Trend -50.10% |
| 9. EPS Trend -68.53% |
What is the price of SWBI shares?
As of December 07, 2025, the stock is trading at USD 10.96 with a total of 3,442,519 shares traded.
Over the past week, the price has changed by +25.83%, over one month by +15.25%, over three months by +27.16% and over the past year by -15.11%.
Over the past week, the price has changed by +25.83%, over one month by +15.25%, over three months by +27.16% and over the past year by -15.11%.
Is SWBI a buy, sell or hold?
Smith & Wesson Brands has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy SWBI.
- Strong Buy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SWBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | 9.5% |
| Analysts Target Price | 12 | 9.5% |
| ValueRay Target Price | 11 | 0.6% |
SWBI Fundamental Data Overview December 05, 2025
Market Cap USD = 393.8m (393.8m USD * 1.0 USD.USD)
P/E Trailing = 34.1538
P/S = 0.8353
P/B = 1.0569
Beta = 1.113
Revenue TTM = 471.4m USD
EBIT TTM = 22.8m USD
EBITDA TTM = 55.1m USD
Long Term Debt = 94.1m USD (from longTermDebt, last quarter)
Short Term Debt = 3.92m USD (from shortTermDebt, last quarter)
Debt = 129.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 111.4m USD (from netDebt column, last quarter)
Enterprise Value = 501.9m USD (393.8m + Debt 129.4m - CCE 21.2m)
Interest Coverage Ratio = 4.48 (Ebit TTM 22.8m / Interest Expense TTM 5.09m)
FCF Yield = 0.45% (FCF TTM 2.24m / Enterprise Value 501.9m)
FCF Margin = 0.47% (FCF TTM 2.24m / Revenue TTM 471.4m)
Net Margin = 2.57% (Net Income TTM 12.1m / Revenue TTM 471.4m)
Gross Margin = 26.54% ((Revenue TTM 471.4m - Cost of Revenue TTM 346.3m) / Revenue TTM)
Gross Margin QoQ = 25.95% (prev 28.80%)
Tobins Q-Ratio = 0.90 (Enterprise Value 501.9m / Total Assets 554.6m)
Interest Expense / Debt = 0.93% (Interest Expense 1.21m / Debt 129.4m)
Taxrate = 16.83% (-690.0k / -4.10m)
NOPAT = 19.0m (EBIT 22.8m * (1 - 16.83%))
Current Ratio = 5.21 (Total Current Assets 275.5m / Total Current Liabilities 52.9m)
Debt / Equity = 0.36 (Debt 129.4m / totalStockholderEquity, last quarter 364.4m)
Debt / EBITDA = 2.02 (Net Debt 111.4m / EBITDA 55.1m)
Debt / FCF = 49.78 (Net Debt 111.4m / FCF TTM 2.24m)
Total Stockholder Equity = 367.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 12.1m / Total Assets 554.6m)
RoE = 3.30% (Net Income TTM 12.1m / Total Stockholder Equity 367.5m)
RoCE = 4.95% (EBIT 22.8m / Capital Employed (Equity 367.5m + L.T.Debt 94.1m))
RoIC = 4.10% (NOPAT 19.0m / Invested Capital 462.8m)
WACC = 6.36% (E(393.8m)/V(523.1m) * Re(8.20%) + D(129.4m)/V(523.1m) * Rd(0.93%) * (1-Tc(0.17)))
Discount Rate = 8.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.29%
[DCF Debug] Terminal Value 69.77% ; FCFE base≈2.24m ; Y1≈1.47m ; Y5≈671.9k
Fair Price DCF = 0.29 (DCF Value 12.9m / Shares Outstanding 44.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -68.53 | EPS CAGR: -42.99% | SUE: -0.40 | # QB: 0
Revenue Correlation: -50.10 | Revenue CAGR: -23.34% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.03 | Chg30d=+0.040 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-04-30): EPS=0.17 | Chg30d=+0.125 | Revisions Net=+1 | Growth EPS=-50.0% | Growth Revenue=-3.1%
EPS next Year (2027-04-30): EPS=0.28 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+69.7% | Growth Revenue=+3.6%
P/E Trailing = 34.1538
P/S = 0.8353
P/B = 1.0569
Beta = 1.113
Revenue TTM = 471.4m USD
EBIT TTM = 22.8m USD
EBITDA TTM = 55.1m USD
Long Term Debt = 94.1m USD (from longTermDebt, last quarter)
Short Term Debt = 3.92m USD (from shortTermDebt, last quarter)
Debt = 129.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 111.4m USD (from netDebt column, last quarter)
Enterprise Value = 501.9m USD (393.8m + Debt 129.4m - CCE 21.2m)
Interest Coverage Ratio = 4.48 (Ebit TTM 22.8m / Interest Expense TTM 5.09m)
FCF Yield = 0.45% (FCF TTM 2.24m / Enterprise Value 501.9m)
FCF Margin = 0.47% (FCF TTM 2.24m / Revenue TTM 471.4m)
Net Margin = 2.57% (Net Income TTM 12.1m / Revenue TTM 471.4m)
Gross Margin = 26.54% ((Revenue TTM 471.4m - Cost of Revenue TTM 346.3m) / Revenue TTM)
Gross Margin QoQ = 25.95% (prev 28.80%)
Tobins Q-Ratio = 0.90 (Enterprise Value 501.9m / Total Assets 554.6m)
Interest Expense / Debt = 0.93% (Interest Expense 1.21m / Debt 129.4m)
Taxrate = 16.83% (-690.0k / -4.10m)
NOPAT = 19.0m (EBIT 22.8m * (1 - 16.83%))
Current Ratio = 5.21 (Total Current Assets 275.5m / Total Current Liabilities 52.9m)
Debt / Equity = 0.36 (Debt 129.4m / totalStockholderEquity, last quarter 364.4m)
Debt / EBITDA = 2.02 (Net Debt 111.4m / EBITDA 55.1m)
Debt / FCF = 49.78 (Net Debt 111.4m / FCF TTM 2.24m)
Total Stockholder Equity = 367.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 12.1m / Total Assets 554.6m)
RoE = 3.30% (Net Income TTM 12.1m / Total Stockholder Equity 367.5m)
RoCE = 4.95% (EBIT 22.8m / Capital Employed (Equity 367.5m + L.T.Debt 94.1m))
RoIC = 4.10% (NOPAT 19.0m / Invested Capital 462.8m)
WACC = 6.36% (E(393.8m)/V(523.1m) * Re(8.20%) + D(129.4m)/V(523.1m) * Rd(0.93%) * (1-Tc(0.17)))
Discount Rate = 8.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.29%
[DCF Debug] Terminal Value 69.77% ; FCFE base≈2.24m ; Y1≈1.47m ; Y5≈671.9k
Fair Price DCF = 0.29 (DCF Value 12.9m / Shares Outstanding 44.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -68.53 | EPS CAGR: -42.99% | SUE: -0.40 | # QB: 0
Revenue Correlation: -50.10 | Revenue CAGR: -23.34% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.03 | Chg30d=+0.040 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-04-30): EPS=0.17 | Chg30d=+0.125 | Revisions Net=+1 | Growth EPS=-50.0% | Growth Revenue=-3.1%
EPS next Year (2027-04-30): EPS=0.28 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+69.7% | Growth Revenue=+3.6%
Additional Sources for SWBI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle